regadenoson has been researched along with Disease Exacerbation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Erinne, I; Kempf, J | 1 |
| Bednárová, V; Kamínek, M; Kincl, V; Máchal, J; Panovský, R; Vašina, J | 1 |
2 other study(ies) available for regadenoson and Disease Exacerbation
| Article | Year |
|---|---|
Incidental Detection of Locally Progressed Pancreatic Cancer on SPECT Myocardial Perfusion Images.
Topics: Aged, 80 and over; Bile Ducts; Dilatation; Disease Progression; Echocardiography; Humans; Incidental Findings; Liver; Male; Myocardial Perfusion Imaging; Organophosphorus Compounds; Organotechnetium Compounds; Pancreatic Neoplasms; Perfusion; Purines; Pyrazoles; Syncope; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2020 |
The prognostic value of ultra low-dose thallium myocardial perfusion protocol using CZT SPECT.
Topics: Aged; Cadmium; Coronary Circulation; Disease Progression; Equipment Design; Exercise Test; Female; Gamma Cameras; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardial Perfusion Imaging; Pilot Projects; Predictive Value of Tests; Prognosis; Purines; Pyrazoles; Radiation Dosage; Radiation Exposure; Radiopharmaceuticals; Reproducibility of Results; Tellurium; Thallium Radioisotopes; Time Factors; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents; Zinc | 2019 |